FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093975812> ?p ?o ?g. }

• W2093975812 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCGenetic alterations in the Ras/Raf/MEK/ERK pathway are among the most common in human cancers. Up to 70% of melanomas harbor B-Raf mutations, and roughly 90% of pancreatic tumors have K-Ras mutations. To address these Raf pathway-driven cancers, small molecule Raf kinase inhibitors have been developed and are currently under clinical investigation. In B-RafV600E cells, Raf compounds inhibit signaling through MEK and ERK, resulting in the expected anti-proliferative effects. Paradoxically, in wild-type Raf cells and in mutant Ras cells, these compounds induce downstream signaling and can induce cell growth in some settings in vitro. While the induction of downstream signaling has previously been attributed to published Raf pathway feedback loops, this has not been proven directly. In fact, we show here that induction of pMEK and pERK can occur within minutes of Raf compound treatment, even before reported feedback phosphorylation events are seen on B-Raf and C-Raf. Interestingly, the induction of signaling and cell growth both occur in a biphasic pattern, with low compound concentrations (0.01-0.1 uM) causing maximal induction, and higher compound concentrations (1-10 uM) causing less profound induction. Such a biphasic pattern is also observed in biochemical assays with purified wild-type B-Raf or C-Raf. The biphasic pattern is suggestive of a mechanism involving the interaction of two signaling subunits. In addition, recent literature data (Rajakulendran, Nature, 461:542-6) has demonstrated that Raf dimerization can upregulate pMEK, not through trans-phosphorylation of Raf molecules but presumably by conformational activation of the kinase. Consistent with that model, we show that Raf compound treatment induces B/C-Raf dimer formation in cells. In addition, knockdown of A-, B- or C-Raf with siRNA does not abrogate the Raf compound induction of pMEK and pERK, suggesting that induction might be mediated by Raf homo- as well as hetero-dimerization. Notably, knockdown of K-Ras in K-RasMUT cells also does not abolish the induction, implying that this effect is not mediated by Ras. Taken together, these data suggest a model in which compound binding to one Raf molecule induces dimerization and conformational activation of a partner Raf molecule in the dimer. These observations can explain why wild-type Raf and mutant Ras tumors are insensitive to selective Raf kinase inhibitors and might also have important implications for toxicity, since induction of strong mitogenic signaling could lead to hyperproliferation of normal tissues. Understanding the Raf compound induction mechanism may lead not only to the design of improved inhibitors, but also to methods for overcoming the induction seen with current development compounds. Toward that end, we show that combining a MEK inhibitor with a Raf compound causes inhibition of both pERK and cell growth and may therefore have significant advantages in the clinic.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 20." @default.
• W2093975812 created "2016-06-24" @default.
• W2093975812 creator A5010721455 @default.
• W2093975812 creator A5022043476 @default.
• W2093975812 creator A5023646977 @default.
• W2093975812 creator A5028312184 @default.
• W2093975812 creator A5042612584 @default.
• W2093975812 creator A5049101929 @default.
• W2093975812 creator A5049772515 @default.
• W2093975812 creator A5053227790 @default.
• W2093975812 creator A5062375703 @default.
• W2093975812 creator A5069559748 @default.
• W2093975812 creator A5073745226 @default.
• W2093975812 creator A5079140306 @default.
• W2093975812 creator A5089990846 @default.
• W2093975812 date "2010-04-15" @default.
• W2093975812 modified "2023-09-27" @default.
• W2093975812 title "Abstract 20: Raf kinase inhibitors can induce Raf dimerization, downstream signaling, and cell growth" @default.
• W2093975812 doi "https://doi.org/10.1158/1538-7445.am10-20" @default.
• W2093975812 hasPublicationYear "2010" @default.
• W2093975812 type Work @default.
• W2093975812 sameAs 2093975812 @default.
• W2093975812 citedByCount "0" @default.
• W2093975812 crossrefType "proceedings-article" @default.
• W2093975812 hasAuthorship W2093975812A5010721455 @default.
• W2093975812 hasAuthorship W2093975812A5022043476 @default.
• W2093975812 hasAuthorship W2093975812A5023646977 @default.
• W2093975812 hasAuthorship W2093975812A5028312184 @default.
• W2093975812 hasAuthorship W2093975812A5042612584 @default.
• W2093975812 hasAuthorship W2093975812A5049101929 @default.
• W2093975812 hasAuthorship W2093975812A5049772515 @default.
• W2093975812 hasAuthorship W2093975812A5053227790 @default.
• W2093975812 hasAuthorship W2093975812A5062375703 @default.
• W2093975812 hasAuthorship W2093975812A5069559748 @default.
• W2093975812 hasAuthorship W2093975812A5073745226 @default.
• W2093975812 hasAuthorship W2093975812A5079140306 @default.
• W2093975812 hasAuthorship W2093975812A5089990846 @default.
• W2093975812 hasConcept C104317684 @default.
• W2093975812 hasConcept C11960822 @default.
• W2093975812 hasConcept C143065580 @default.
• W2093975812 hasConcept C150555746 @default.
• W2093975812 hasConcept C184235292 @default.
• W2093975812 hasConcept C185592680 @default.
• W2093975812 hasConcept C502942594 @default.
• W2093975812 hasConcept C55493867 @default.
• W2093975812 hasConcept C57074206 @default.
• W2093975812 hasConcept C62112901 @default.
• W2093975812 hasConcept C62478195 @default.
• W2093975812 hasConcept C86803240 @default.
• W2093975812 hasConcept C95444343 @default.
• W2093975812 hasConceptScore W2093975812C104317684 @default.
• W2093975812 hasConceptScore W2093975812C11960822 @default.
• W2093975812 hasConceptScore W2093975812C143065580 @default.
• W2093975812 hasConceptScore W2093975812C150555746 @default.
• W2093975812 hasConceptScore W2093975812C184235292 @default.
• W2093975812 hasConceptScore W2093975812C185592680 @default.
• W2093975812 hasConceptScore W2093975812C502942594 @default.
• W2093975812 hasConceptScore W2093975812C55493867 @default.
• W2093975812 hasConceptScore W2093975812C57074206 @default.
• W2093975812 hasConceptScore W2093975812C62112901 @default.
• W2093975812 hasConceptScore W2093975812C62478195 @default.
• W2093975812 hasConceptScore W2093975812C86803240 @default.
• W2093975812 hasConceptScore W2093975812C95444343 @default.
• W2093975812 hasLocation W20939758121 @default.
• W2093975812 hasOpenAccess W2093975812 @default.
• W2093975812 hasPrimaryLocation W20939758121 @default.
• W2093975812 hasRelatedWork W1975664568 @default.
• W2093975812 hasRelatedWork W1978168320 @default.
• W2093975812 hasRelatedWork W1992430732 @default.
• W2093975812 hasRelatedWork W2002809596 @default.
• W2093975812 hasRelatedWork W2022971311 @default.
• W2093975812 hasRelatedWork W2024843536 @default.
• W2093975812 hasRelatedWork W2028225374 @default.
• W2093975812 hasRelatedWork W2030246021 @default.
• W2093975812 hasRelatedWork W2044481116 @default.
• W2093975812 hasRelatedWork W2045055190 @default.
• W2093975812 hasRelatedWork W2059668261 @default.
• W2093975812 hasRelatedWork W2064704783 @default.
• W2093975812 hasRelatedWork W2080094132 @default.
• W2093975812 hasRelatedWork W2127322842 @default.
• W2093975812 hasRelatedWork W2151489147 @default.
• W2093975812 hasRelatedWork W2156925139 @default.
• W2093975812 hasRelatedWork W2750819032 @default.
• W2093975812 hasRelatedWork W3038485915 @default.
• W2093975812 hasRelatedWork W2347561595 @default.
• W2093975812 hasRelatedWork W2526727685 @default.
• W2093975812 isParatext "false" @default.
• W2093975812 isRetracted "false" @default.
• W2093975812 magId "2093975812" @default.
• W2093975812 workType "article" @default.